Thomas Shrader
Stock Analyst at BTIG
(4.10)
# 1,565
Out of 4,423 analysts
730
Total ratings
39.6%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRD Opus Genetics | Maintained: Buy | $12 | $4.07 | +194.84% | 5 | Jun 16, 2026 | |
| NVAX Novavax | Maintained: Buy | $19 | $9.13 | +108.11% | 8 | Jun 11, 2026 | |
| IVVD Invivyd | Maintained: Buy | $10 | $0.9699 | +931.03% | 7 | Jun 11, 2026 | |
| GANX Gain Therapeutics | Maintained: Buy | $5 | $1.88 | +165.96% | 29 | May 26, 2026 | |
| NTHI NeOnc Technologies Holdings | Rated: Buy | $15 | $5.27 | +184.63% | 2 | May 26, 2026 | |
| CMPS COMPASS Pathways | Maintained: Buy | $14 | $12.53 | +11.73% | 14 | May 13, 2026 | |
| ANRO Alto Neuroscience | Maintained: Buy | $28 | $22.74 | +23.13% | 7 | May 13, 2026 | |
| BIOA BioAge Labs | Initiated Coverage: Buy | $40 | $20.77 | +92.59% | 1 | May 13, 2026 | |
| HROW Harrow | Maintained: Buy | $63 | $42.87 | +46.96% | 10 | May 12, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | $39 | $23.31 | +67.31% | 37 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $31.00 | +25.81% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $196.58 | - | 50 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.75 | +242.86% | 25 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.26 | +253.98% | 29 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $147 | $60.66 | +142.33% | 6 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.27 | +76.21% | 17 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $3.97 | +529.72% | 12 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.96 | +359.18% | 33 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.40 | +233.33% | 7 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $4.92 | +225.20% | 24 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $7.53 | +205.44% | 10 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $89 | $51.44 | +73.02% | 26 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $13.57 | +17.91% | 28 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.45 | - | 32 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $200 | $10.54 | +1,797.53% | 7 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.44 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $3.15 | n/a | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.05 | n/a | 14 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $0.0001 | n/a | 6 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $1.16 | n/a | 16 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.7535 | n/a | 5 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $66.27 | n/a | 20 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 → $15 | $6.93 | n/a | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.90 | n/a | 5 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.47 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $216 | $11.90 | n/a | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $87 → $13 | $3.66 | n/a | 5 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $12 | $4.13 | n/a | 8 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.56 | n/a | 4 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $15.03 | n/a | 2 | Mar 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 | $12.64 | n/a | 4 | Mar 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $57 → $70 | $24.31 | n/a | 5 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.71 | n/a | 4 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $28.46 | n/a | 7 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 7 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $6.78 | n/a | 5 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $10.19 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.000001 | n/a | 3 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 | $0.8278 | n/a | 4 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.26 | n/a | 9 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.72 | n/a | 8 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.11 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $29.63 | n/a | 1 | Oct 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $39 | $4.82 | n/a | 12 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $26 | $9.63 | n/a | 4 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $12 | $35.04 | n/a | 4 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $40 | $10.28 | n/a | 5 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $76 | $57.51 | n/a | 3 | Oct 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.12 | n/a | 17 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $130 | $7.56 | n/a | 7 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $17.82 | n/a | 2 | Jul 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 | $0.01699 | n/a | 1 | Jun 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $38 | $6.76 | n/a | 9 | Jun 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.2 → $11 | $3.92 | n/a | 4 | Dec 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $123.76 | n/a | 1 | Mar 23, 2015 |
Opus Genetics
Jun 16, 2026
Maintained: Buy
Price Target: $12
Current: $4.07
Upside: +194.84%
Novavax
Jun 11, 2026
Maintained: Buy
Price Target: $19
Current: $9.13
Upside: +108.11%
Invivyd
Jun 11, 2026
Maintained: Buy
Price Target: $10
Current: $0.9699
Upside: +931.03%
Gain Therapeutics
May 26, 2026
Maintained: Buy
Price Target: $5
Current: $1.88
Upside: +165.96%
NeOnc Technologies Holdings
May 26, 2026
Rated: Buy
Price Target: $15
Current: $5.27
Upside: +184.63%
COMPASS Pathways
May 13, 2026
Maintained: Buy
Price Target: $14
Current: $12.53
Upside: +11.73%
Alto Neuroscience
May 13, 2026
Maintained: Buy
Price Target: $28
Current: $22.74
Upside: +23.13%
BioAge Labs
May 13, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $20.77
Upside: +92.59%
Harrow
May 12, 2026
Maintained: Buy
Price Target: $63
Current: $42.87
Upside: +46.96%
Denali Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $39
Current: $23.31
Upside: +67.31%
May 11, 2026
Maintained: Buy
Price Target: $39
Current: $31.00
Upside: +25.81%
Apr 20, 2026
Maintained: Hold
Price Target: n/a
Current: $196.58
Upside: -
Apr 2, 2026
Maintained: Buy
Price Target: $6
Current: $1.75
Upside: +242.86%
Apr 2, 2026
Maintained: Buy
Price Target: $8
Current: $2.26
Upside: +253.98%
Mar 30, 2026
Maintained: Buy
Price Target: $147
Current: $60.66
Upside: +142.33%
Mar 26, 2026
Maintained: Buy
Price Target: $4
Current: $2.27
Upside: +76.21%
Mar 24, 2026
Maintained: Buy
Price Target: $25
Current: $3.97
Upside: +529.72%
Mar 17, 2026
Maintained: Buy
Price Target: $9
Current: $1.96
Upside: +359.18%
Mar 16, 2026
Maintained: Buy
Price Target: $8
Current: $2.40
Upside: +233.33%
Mar 16, 2026
Maintained: Buy
Price Target: $16
Current: $4.92
Upside: +225.20%
Mar 3, 2026
Maintained: Buy
Price Target: $23
Current: $7.53
Upside: +205.44%
Mar 2, 2026
Maintained: Buy
Price Target: $89
Current: $51.44
Upside: +73.02%
Nov 17, 2025
Maintained: Buy
Price Target: $16
Current: $13.57
Upside: +17.91%
Nov 3, 2025
Maintained: Hold
Price Target: n/a
Current: $1.45
Upside: -
Jul 21, 2025
Maintained: Buy
Price Target: $8 → $200
Current: $10.54
Upside: +1,797.53%
May 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $5.44
Upside: n/a
Mar 4, 2025
Maintained: Buy
Price Target: $9
Current: $3.15
Upside: n/a
Mar 2, 2025
Maintained: Hold
Price Target: n/a
Current: $8.05
Upside: n/a
Mar 19, 2024
Maintained: Buy
Price Target: $32
Current: $0.0001
Upside: n/a
Feb 28, 2024
Maintained: Buy
Price Target: $33
Current: $1.16
Upside: n/a
Jan 5, 2024
Maintained: Buy
Price Target: n/a
Current: $0.7535
Upside: n/a
Nov 17, 2023
Rated: Hold
Price Target: n/a
Current: $66.27
Upside: n/a
Nov 14, 2023
Rated: Buy
Price Target: $32 → $15
Current: $6.93
Upside: n/a
Aug 4, 2023
Rated: Hold
Price Target: n/a
Current: $4.90
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $4.47
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $216
Current: $11.90
Upside: n/a
Mar 27, 2023
Maintained: Buy
Price Target: $87 → $13
Current: $3.66
Upside: n/a
Mar 20, 2023
Rated: Buy
Price Target: $50 → $12
Current: $4.13
Upside: n/a
Mar 20, 2023
Reiterated: Hold
Price Target: n/a
Current: $5.56
Upside: n/a
Mar 12, 2023
Rated: Buy
Price Target: $20
Current: $15.03
Upside: n/a
Mar 5, 2023
Maintained: Buy
Price Target: $56
Current: $12.64
Upside: n/a
Mar 2, 2023
Rated: Buy
Price Target: $57 → $70
Current: $24.31
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $0.71
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $28.46
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Sep 9, 2021
Rated: Buy
Price Target: $16
Current: $6.78
Upside: n/a
Aug 6, 2021
Maintained: Buy
Price Target: $60
Current: $10.19
Upside: n/a
Jul 6, 2021
Rated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Jun 10, 2021
Maintained: Buy
Price Target: $5.5
Current: $0.8278
Upside: n/a
Jun 4, 2021
Rated: Hold
Price Target: n/a
Current: $1.26
Upside: n/a
May 10, 2021
Maintained: Hold
Price Target: n/a
Current: $3.72
Upside: n/a
Sep 23, 2020
Downgraded: Hold
Price Target: n/a
Current: $1.11
Upside: n/a
Oct 6, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $29.63
Upside: n/a
Nov 9, 2017
Reiterated: Buy
Price Target: $57 → $39
Current: $4.82
Upside: n/a
Nov 7, 2017
Maintained: Buy
Price Target: $32 → $26
Current: $9.63
Upside: n/a
Nov 1, 2017
Reiterated: Buy
Price Target: $14 → $12
Current: $35.04
Upside: n/a
Oct 17, 2017
Reiterated: Buy
Price Target: $20 → $40
Current: $10.28
Upside: n/a
Oct 10, 2017
Reiterated: Buy
Price Target: $35 → $76
Current: $57.51
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $11
Current: $1.12
Upside: n/a
Oct 2, 2017
Rated: Buy
Price Target: $110 → $130
Current: $7.56
Upside: n/a
Jul 24, 2017
Reiterated: Buy
Price Target: $24
Current: $17.82
Upside: n/a
Jun 30, 2017
Downgraded: Hold
Price Target: $6
Current: $0.01699
Upside: n/a
Jun 21, 2017
Maintained: Buy
Price Target: $32 → $38
Current: $6.76
Upside: n/a
Dec 22, 2016
Reiterated: Hold
Price Target: $1.2 → $11
Current: $3.92
Upside: n/a
Mar 23, 2015
Downgraded: Hold
Price Target: n/a
Current: $123.76
Upside: n/a